搜索
Ascendis Pharma A/S
ASND添加自选
238.670USD
+0.010+0.00%
收盘 05/11, 16:00（美东）报价延迟15分钟
14.79B总市值
34.39市盈率 TTM
关于 Ascendis Pharma A/S 公司
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ascendis Pharma A/S简介
公司代码ASND
公司名称Ascendis Pharma A/S
上市日期Jan 28, 2015
CEOMoller Mikkelsen (Jan)
员工数量- -
证券类型Depository Receipt
年结日Jan 28
公司地址Tuborg Boulevard 12
城市HELLERUP
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Denmark
邮编2900
电话4570222244
网址https://ascendispharma.dk/
公司代码ASND
上市日期Jan 28, 2015
CEOMoller Mikkelsen (Jan)
Ascendis Pharma A/S公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+66.49%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.66K
+40.20%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Mr. Jan Moller Mikkelsen
Mr. Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
President, Chief Executive Officer, Executive Director, Member of the Executive Board
--
--
Ms. Lotte Soenderbjerg
Ms. Lotte Soenderbjerg
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
Executive Vice President, Chief Administrative Officer, Member of the Executive Board
--
--
Dr. Kennett Sprogoee, Ph.D.
Dr. Kennett Sprogoee, Ph.D.
Executive Vice President, Head of Innovation and Research
Executive Vice President, Head of Innovation and Research
--
--
Mr. Scott T. Smith
Mr. Scott T. Smith
Chief Financial Officer, Executive Vice President, Member of the Executive Board
Chief Financial Officer, Executive Vice President, Member of the Executive Board
--
--
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
--
-100.00%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+66.49%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.66K
+40.20%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Mr. Jan Moller Mikkelsen
Mr. Jan Moller Mikkelsen
President, Chief Executive Officer, Executive Director, Member of the Executive Board
President, Chief Executive Officer, Executive Director, Member of the Executive Board
--
--
收入明细
单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Commercial sale of products
683.57M
94.92%
Rendering of services
18.01M
2.50%
Milestones
12.92M
1.79%
License
5.63M
0.78%
地区USD
名称
营收
占比
North America
546.39M
75.87%
Europe
108.05M
15.00%
Rest of world
52.80M
7.33%
Denmark
12.90M
1.79%
业务
地区
业务USD
名称
营收
占比
Commercial sale of products
683.57M
94.92%
Rendering of services
18.01M
2.50%
Milestones
12.92M
1.79%
License
5.63M
0.78%
股东统计
更新时间: 23 小时前
更新时间: 23 小时前
持股股东
股东类型
持股股东
持股股东
占比
RA Capital Management, LP
16.55%
Westfield Capital Management Company, L.P.
8.35%
Avoro Capital Advisors LLC
8.23%
Janus Henderson Investors
6.54%
Fidelity Management & Research Company LLC
6.12%
其他
54.21%
持股股东
持股股东
占比
RA Capital Management, LP
16.55%
Westfield Capital Management Company, L.P.
8.35%
Avoro Capital Advisors LLC
8.23%
Janus Henderson Investors
6.54%
Fidelity Management & Research Company LLC
6.12%
其他
54.21%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
42.09%
Investment Advisor
40.09%
Venture Capital
16.77%
Hedge Fund
6.19%
Research Firm
3.18%
Private Equity
2.23%
Individual Investor
0.82%
Pension Fund
0.43%
Sovereign Wealth Fund
0.38%
机构持股
更新时间: 4月5日 周日
更新时间: 4月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2026Q1
582
69.20M
111.42%
-1.68M
2025Q4
523
68.62M
116.45%
+3.30K
2025Q3
540
68.73M
112.39%
+4.25M
2025Q2
515
64.43M
118.51%
-2.60M
2025Q1
495
67.05M
117.13%
-3.67M
2024Q4
471
65.26M
121.58%
+1.14M
2024Q3
461
64.02M
116.74%
+1.57M
2024Q2
446
62.31M
123.50%
-4.72K
2024Q1
440
62.32M
122.74%
-9.15M
2023Q4
415
61.74M
123.84%
-59.49K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RA Capital Management, LP
10.28M
16.59%
--
--
Dec 31, 2025
Westfield Capital Management Company, L.P.
5.19M
8.37%
-74.21K
-1.41%
Dec 31, 2025
Avoro Capital Advisors LLC
5.11M
8.25%
+1.11K
+0.02%
Dec 31, 2025
Janus Henderson Investors
4.06M
6.55%
-261.42K
-6.05%
Dec 31, 2025
Fidelity Management & Research Company LLC
3.80M
6.13%
-317.86K
-7.72%
Dec 31, 2025
Artisan Partners Limited Partnership
3.23M
5.2%
-495.00K
-13.30%
Dec 31, 2025
Capital International Investors
3.06M
4.94%
+3.33K
+0.11%
Dec 31, 2025
MFS Investment Management
1.88M
3.04%
+3.94K
+0.21%
Dec 31, 2025
Wellington Management Company, LLP
1.76M
2.84%
-36.21K
-2.01%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
1.67M
2.69%
-998.99K
-37.46%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Harbor Health Care ETF
17.71%
American Century Focused Dynamic Growth ETF
2.8%
AdvisorShares Dorsey Wright ADR ETF
2.62%
Virtus LifeSci Biotech Products ETF
1.89%
Tema Heart & Health ETF
1.45%
ProShares Ultra Nasdaq Biotechnology
1.2%
Invesco Nasdaq Biotechnology ETF
1.19%
First Trust Innovation Leaders ETF
1.18%
Putnam Sustainable Future ETF
1.11%
Main Thematic Innovation ETF
1.07%
查看更多
Harbor Health Care ETF
占比17.71%
American Century Focused Dynamic Growth ETF
占比2.8%
AdvisorShares Dorsey Wright ADR ETF
占比2.62%
Virtus LifeSci Biotech Products ETF
占比1.89%
Tema Heart & Health ETF
占比1.45%
ProShares Ultra Nasdaq Biotechnology
占比1.2%
Invesco Nasdaq Biotechnology ETF
占比1.19%
First Trust Innovation Leaders ETF
占比1.18%
Putnam Sustainable Future ETF
占比1.11%
Main Thematic Innovation ETF
占比1.07%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
